Enrollment underway in Revance Therapeutics' late-stage DaxibotulinumtoxinA study
April 27 2021 - 7:35AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Apr 2024 to May 2024
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From May 2023 to May 2024